TotalMarketCap

First Tracks Biotherapeutics

TRAXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.915 B

$45.58 -7.05%

Close of 6 Nov 2026

As of 6 Nov 2026, First Tracks Biotherapeutics (TRAX) has a market capitalization of $1.92B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$166.1M

Loss-making

Shares outstanding

42,017,901

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #95BiohavenBHVN$2.09B
  2. #96ZymeworksZYME$2.03B
  3. #97First Tracks BiotherapeuticsTRAX$1.92B
  4. #98Harmony BiosciencesHRMY$1.91B
  5. #99Sarepta TherapeuticsSRPT$1.85B

What if First Tracks Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$672,020.10

Per share 14,744× higher

Bitcoin $1.53T

$36,361.84

Per share 798× higher

Apple $5.02T

$119,372.52

Per share 2,619× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for First Tracks Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.